Baxter International Boosts FY24 Outlook - Update
(RTTNews) - While reporting financial results for the second quarter on Tuesday, health care company Baxter International Inc. (BAX) raised its earnings, adjusted earnings and sales growth guidance for the full-year 2024. The company also provided outlook for the third quarter.
For the third quarter, the company anticipates adjusted earnings in a range of $0.77 to $0.79 per share on sales growth of 3 to 4 percent on a reported basis and constant currency basis.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.74 per share on revenues of $3.79 billion for the quarter. Analysts' estimates typically exclude special items.
Looking ahead to fiscal 2024, the company now projects adjusted earnings in a range of $2.93 to $3.01 per share on sales growth of about 3 percent on a reported and constant currency basis.
Previously, the company expected adjusted earnings in the range of $2.88 to $2.98 per share on sales growth of about 2 percent on a reported basis and 2 to 3 percent on a constant currency basis.
The Street is looking for earnings of 2.92 per share on revenue growth of 2.0 percent to $15.12 billion for the quarter.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Baxter Int'l Names Proposed Kidney Care Spinoff As Vantive
Baxter Int'l Launches PERCLOT Absorbable Hemostatic Powder In The US
Baxter International Q1 Results Top Estimates; Boosts FY23 Adj. EPS Outlook
Baxter Int'l Announces US Launch Of ZOSYN Premix
Baxter International Guides Q1, FY23 Adj. EPS Well Below Estimates; To Cut 5% Jobs - Update
Baxter International Again Slashes FY22 Outlook - Update
TSX Ends Modestly Lower, Drops Nearly 1.5% In Week
